Roche and Lil­ly team up to de­vel­op blood test to de­tect ear­ly signs of Alzheimer's

Eli Lil­ly is team­ing up with Roche to help de­vel­op a blood test to de­tect ear­ly signs of Alzheimer’s dis­ease and de­ter­mine whether a pa­tient should go for fur­ther con­fir­ma­to­ry test­ing.

Roche’s Elec­sys Amy­loid Plas­ma Pan­el (EAPP) mea­sures pTau 181 pro­tein as­say and APOE E4 as­say in hu­man blood plas­ma – el­e­va­tions in pTau 181 are present in the ear­ly stages of Alzheimer’s, while the pres­ence of APO E4 is the most com­mon ge­net­ic risk fac­tor for the dis­ease.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER